Skip to main content

Table 4 Blood markers obtained before and after supplementation with AHE or placeboa

From: A randomized, double-blind, placebo-controlled crossover clinical trial to evaluate the anti-diabetic effects of Allium hookeri extract in the subjects with prediabetes

 

Test group (n = 22)

Placebo group (n = 22)

P-valueb

Week 0

Week 8

Change value

Week 0

Week 8

Change value

Insulin (μU/mL)

8.52 ± 4.38

10.41 ± 5.00

1.89 ± 3.53

9.32 ± 4.42

9.26 ± 5.19

−0.06 ± 3.08

0.094

C-peptide (ng/mL)

2.00 ± 0.77

2.23 ± 0.69

0.23 ± 0.50

2.07 ± 0.77

2.18 ± 0.90

0.11 ± 0.38

0.448

HbA1c (%)

6.24 ± 0.38

6.20 ± 0.37

−0.04 ± 0.12

6.19 ± 0.37

6.26 ± 0.39

0.07 ± 0.15

0.012

Total cholesterol (mg/dL)

213.86 ± 27.18

212.68 ± 24.87

−1.18 ± 28.03

219.27 ± 21.88

217.68 ± 25.36

−1.59 ± 18.98

0.963

Triglycerides (mg/dL)

180.77 ± 117.66

170.09 ± 109.94

−10.68 ± 34.42

160.86 ± 75.71

157.32 ± 74.26

−3.55 ± 84.89

0.730

HDL-cholesterol (mg/dL)

49.27 ± 9.52

49.68 ± 8.25

0.41 ± 5.43

50.64 ± 9.42

48.45 ± 8.32

−2.18 ± 6.18

0.201

LDL-cholesterol (mg/dL)

133.86 ± 19.11

135.23 ± 19.86

1.36 ± 25.42

145.00 ± 18.97

143.82 ± 24.50

−1.18 ± 17.76

0.759

  1. AHE Allium hookeri extract; HbA1c hemoglobin A1c
  2. aValues are presented as mean ± standard deviation
  3. bAnalyzed using t-test (difference between two groups in change from baseline)